why choose us

First received: June 14, 2024

Clinical Trial: A Real-world, Prospective Observational Study of Rimegepant ODT for the Acute Treatment of Migraine Attacks in Adults.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Migraine

Study Type: OBSERVATIONAL


Official Title: CONFIDENCE: A Prospective Observational Study With Acute Treatment of Rimegepant ODT on Consistency, Satisfaction and Tolerability of Treatment in the Real World

Brief Summary: This study aims at characterizing the effectiveness of rimegepant as an acute migraine treatment in a real world setting on two aspects:Consistency of response to rimegepant across multiple attacksEffectiveness of rimegepant in users taking concomitant migraine preventive medications, namely monoclonal antibodies targeting CGRP and onabotulinumtoxinA

Read more